Literature DB >> 1714845

The effects of ovine growth hormone on protein turnover in rainbow trout.

A R Foster1, D F Houlihan, C Gray, F Medale, B Fauconneau, S J Kaushik, P Y Le Bail.   

Abstract

Ovine growth hormone (oGH) was administered to rainbow trout via an intraperitoneal cholesterol implant. After 21 days, plasma oGH levels were recorded as control group, less than 2 ng ml-1, i.e., not detectable, and oGH group, 19.2 +/- 2.8 ng ml-1. oGH-treated fish exhibited significantly increased whole-body growth rates, whole-body protein accretion rates, stimulated tissue protein synthesis, and tissue protein accretion rates. A dramatic decrease in white muscle protein concentration was also observed after oGH treatment. In some tissues (liver and stomach), elevated protein synthesis rates were the result of higher RNA/protein ratios. However, in other tissues (gill and ventricle), increased RNA activity accounted for the differences in rates of protein synthesis. The growth promoting effects of oGH on both whole-body and tissue protein turnover were generally accompanied with no change in the efficiency of deposition of newly synthesized protein. For the same ration size, the oGH group showed higher retentions of ingested nitrogen. It is concluded that oGH significantly enhances whole-body growth rates as a result of the stimulatory effect on protein synthesis rates with little effect on protein degradation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714845     DOI: 10.1016/0016-6480(91)90302-m

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  9 in total

1.  Influence of growth hormone on the hepatic mixed function oxidase and transferase systems of rainbow trout.

Authors:  J P Cravedi; A Paris; E Perdu-Durand; P Prunet
Journal:  Fish Physiol Biochem       Date:  1995-08       Impact factor: 2.794

2.  Somatotropic actions of the homologous growth hormone and prolactins in the euryhaline teleost, the tilapia, Oreochromis mossambicus.

Authors:  B S Shepherd; T Sakamoto; R S Nishioka; N H Richman; I Mori; S S Madsen; T T Chen; T Hirano; H A Bern; E G Grau
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Physiological and endocrinological responses during prolonged exercise in hatchery-reared rainbow trout (Oncorhynchus mykiss).

Authors:  M E Nielsen; L Boesgaard; R M Sweeting; B A McKeown; P Rosenkilde
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

4.  Effect of recombinant human GH and GHRH on plasma metabolite levels in rainbow trout (Oncorhynchus mykiss).

Authors:  M D Hernández Llorente; M J Dato Gómez; J de Costa Ruiz; P Mendiola López; S Zamora Navarro
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

5.  Effect of growth hormone on muscle protein synthesis in rainbow trout (Oncorhynchus mykiss) and Atlantic salmon (Salmo salar).

Authors:  B Fauconneau; M P Mady; P Y Lebail
Journal:  Fish Physiol Biochem       Date:  1996-02       Impact factor: 2.794

6.  Effects of growth hormone on plasma ionic regulation, respiration and extracellular acid-base status in trout (Oncorhynchus mykiss) transferred to seawater.

Authors:  H Seddiki; V Maxime; G Boeuf; C Peyraud
Journal:  Fish Physiol Biochem       Date:  1995-08       Impact factor: 2.794

7.  The energetic cost of protein synthesis in isolated hepatocytes of rainbow trout (Oncorhynchus mykiss).

Authors:  M C Pannevis; D F Houlihan
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

8.  Recombinant Bovine Growth Hormone-Induced Metabolic Remodelling Enhances Growth of Gilthead Sea-Bream (Sparus aurata): Insights from Stable Isotopes Composition and Proteomics.

Authors:  Josefina Blasco; Emilio J Vélez; Miquel Perelló-Amorós; Sheida Azizi; Encarnación Capilla; Jaume Fernández-Borràs; Joaquim Gutiérrez
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

9.  Endocrine regulation of compensatory growth in fish.

Authors:  Eugene T Won; Russell J Borski
Journal:  Front Endocrinol (Lausanne)       Date:  2013-07-01       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.